CD28 and acute myeloid leukemia: NK-92 cell were transduced with the CD4-CD28, 4-1BB-CD3ζ CAR vector to obtain CD4CAR NK-92 cells, which successfully eradicated CD4+ AML cells in vitro and demonstrated robust anti leukemic activity in a CD4+ AML xenograft mouse model (191).